Scientific Advisors

Director, McEwen Centre for Regenerative Medicine, University Health Network of Toronto

Gordon Keller, Ph.D.

Director, McEwen Centre for Regenerative Medicine, University Health Network of Toronto

Dr. Keller is a scientific co-founder of BlueRock Therapeutics and the director of the McEwen Centre for Regenerative Medicine at the University Health Network in Toronto. He is best known for his research in lineage specific differentiation of mouse and human embryonic stem cells. Prior to this role, Dr. Keller was the director of the Black Family Stem Cell Institute at the Mt. Sinai School of Medicine in New York where he previously was a professor in the Department of Gene and Cell Medicine. Dr. Keller earned his Ph.D. in immunology at the University of Alberta.

Senior Scientist, Toronto General Hospital Research Institute

Michael Laflamme, M.D., Ph.D.

Senior Scientist, Toronto General Hospital Research Institute

Dr. Laflamme is a founding investigator of BlueRock Therapeutics and is a senior scientist at Toronto General Hospital Research Institute. Dr. Laflamme is a leader in the field of cardiac physiology, stem cell-derived cardiac tissues and cardiac pacemaker cells. Dr. Laflamme earned an M.D., Ph.D. degree in physiology and pharmacology from Emory University School of Medicine. He holds a Bachelor of Science degree in physics from Georgetown University.

Director, Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center

Lorenz Studer, M.D., Ph.D.

Director, Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center

Dr. Studer is a scientific co-founder of BlueRock Therapeutics and is director of the Center for Stem Cell Biology and member of the Developmental Biology Program at Memorial Sloan Kettering in New York. He is currently leading a multidisciplinary consortium to pursue the clinical application of human stem cell-derived dopamine neurons for the treatment of Parkinson’s disease. Dr. Studer’s work has been recognized by numerous awards including the Boyer Young Investigator award, the Annemarie Opprecht Award and a McArthur Fellowship.

Chair, Department of Neurosurgery; Theresa Feng Chair in Neurosurgical Oncology

Viviane Tabar, M.D.

Chair, Department of Neurosurgery; Theresa Feng Chair in Neurosurgical Oncology

Dr. Tabar is a founding investigator of BlueRock Therapeutics, a neurosurgeon and professor at Memorial Sloan Kettering Cancer Center in New York and holds a joint appointment at Weill Cornell Medical College in the departments of Neurosurgery and Neuroscience. Dr. Tabar serves as a co-principal investigator of a large consortium grant aiming at the development of a clinical trial for grafting human embryonic stem cell–derived dopamine neurons in Parkinson patients and has focused major efforts on the development of human ES-derived oligodendrocytes for brain radiation damage. She received clinical training at the University of Massachusetts and at Memorial Sloan Kettering and research training at the National Institute of Neurological Disorders and Stroke/NIH.

Regents Professor of Pediatrics, Division of Blood and Marrow Transplantation at the University of Minnesota 

Bruce Blazar, M.D.

Regents Professor of Pediatrics, Division of Blood and Marrow Transplantation at the University of Minnesota 

Dr. Bruce Blazar is a Regents Professor of Pediatrics in the Division of Blood and Marrow Transplantation and Associate Vice President in the Office of Academic and Clinical Affairs at the University of Minnesota. He is the founding Director of the Clinical and Translational Sciences Institute and the founding Director of the Center for Translational Medicine at the University of Minnesota. Dr. Blazar’s lab specializes in inflammatory responses associated with hematopoietic stem cell transplants. Over the past 30+ years, his laboratory has focused on transplantation immunobiology in order to develop new therapies to improve patient health. Dr. Blazar is the author of more than 760 manuscripts, which have appeared in premier peer-reviewed publications. Dr. Blazar received his M.D. from Albany Medical College. He is board certified in Pediatrics and Pediatric Hematology/Oncology/Bone Marrow Transplantation after completing a residency and fellowship, respectively at the University of Minnesota.